Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Anticoagulation Alone May Be Better for Patients With CAD

Oral anticoagulation alone is linked to lower risks for cardiovascular death and bleeding than adding an antiplatelet in stable coronary artery disease, with no higher risks for other poor outcomes.

Stents Placed Under Imaging Guidance Yield Better Outcomes

Stenting guided by intravascular imaging rather than angiography is linked to a lower risk for target vessel failure in patients with complex coronary artery lesions, a 5-year follow-up finds.

Med Op-Ed: TAVR Safety Signal, Limits of Famed Biobank, More

Opportunities to improve postmarketing surveillance of heart devices; how to validate findings based on UK Biobank data; and how to approach nonculprit lesions in STEMI.

Acid Blockers or PPI With Clopidogrel Tied to Stroke Risk

The use of potassium-competitive acid blockers or PPI with clopidogrel is associated with a higher risk for ischemic events after stroke than clopidogrel alone, a new study shows.

Clinics Closing the Cardiovascular-Mental Health Gap

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental health care.

Insomnia Plus OSA Tied to Cerebrovascular Disease Risk

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular disease, a new study shows.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Latest News

Oral anticoagulation alone is linked to lower risks for cardiovascular death and bleeding than adding an antiplatelet in stable coronary artery disease, with no higher risks for other poor outcomes.

Stenting guided by intravascular imaging rather than angiography is linked to a lower risk for target vessel failure in patients with complex coronary artery lesions, a 5-year follow-up finds.

Opportunities to improve postmarketing surveillance of heart devices; how to validate findings based on UK Biobank data; and how to approach nonculprit lesions in STEMI.

The use of potassium-competitive acid blockers or PPI with clopidogrel is associated with a higher risk for ischemic events after stroke than clopidogrel alone, a new study shows.

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental health care.

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular disease, a new study shows.

News All Time

1 in 4 Kids at Juvenile Arthritis Onset Have Renal Issues

Acute kidney injury occurs in nearly one quarter of children at the onset of juvenile idiopathic arthritis and increases the risk for long-term kidney damage by more than five times.

Semaglutide Boosts Insulin Sensitivity in Schizophrenia Care

Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.

VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer

Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the randomized COBRRA trial.

New Non-Hormonal Menopause Drug Backed by NICE

NICE has recommended fezolinetant for menopausal hot flushes and night sweats, offering a non-hormonal option when HRT is unsuitable.

CV Risk Increased Across Spectrum of Primary Aldosteronism

Primary aldosteronism may influence cardiovascular risk, even at levels below current diagnostic thresholds in older adults.

Primary Care for Kidney Failure Linked to Fewer ER Visits

Comprehensive care beyond dialysis is critical for patients with end-stage kidney disease.

Evidence Questions Routine Calcium Supplementation for Bones

Evidence from randomized trials suggests that calcium supplements may not significantly reduce fracture risk in well-nourished adults.

Immunofitness: Vaccination for Healthy Aging

A Spanish review suggests vaccines — influenza, RSV, COVID, pneumococcal, zoster, and others — may help preserve immune function in older adults and reduce hospitalizations.

Beyond GLP-1s: Which Weight-Loss Drugs Are on the Way?

Pharmaceutical company investments in novel obesity treatments are soaring in 2026.

Rising Childhood Obesity: Implications for Clinicians

In Brazil, an estimated 6.6 million children aged 5-9 years and 9.9 million adolescents aged 10-19 years are overweight or have obesity; clinicians should prioritize prevention and early intervention.

Sleep Apnea Measure May Predict Postop Complications, Death

In patients with obstructive sleep apnea undergoing major surgery, sleep apnea-specific hypoxic burden is associated with a risk for cardiovascular complications and deaths within 30 days.

PCPs Key to Cardiac Amyloidosis Detection in Obese Patients

The signs may be subtle, but clinicians have clues to look for.

Experts Warn Psychiatric Symptoms May Mask Hidden Disease

Takotsubo syndrome, frontotemporal dementia, gut-brain disorders, and tinnitus share psychiatric features that complicate their diagnosis and management.

Hypertrophic Cardiomyopathy: Do Family Members Face Risk?

Relatives with a pathogenic sarcomere gene variant have a lower risk for serious cardiac events than patients with hypertrophic cardiomyopathy but a higher risk than relatives without the variant.

Statins After 80? Lower Death Risk With Heart Benefit

In adults aged 80 years or older, the use of statins is linked to a lower risk for all-cause mortality and new coronary events.

Recommended News For You

In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

Preferred and Actual Location of Death Often Don't Match for Young Cancer Patients

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

Glioblastoma treatment breakthrough shows promise

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

Recommended Articles For You

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment 

Leukemia: Understanding the Disease and Its Impact on Patients  

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EVP Beats Cisplatin for Resectable MIBC

2.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

3.

In prostate cancer survivorship, sleep disturbances are underappreciated.

4.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

1.

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown

2.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

3.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

4.

Everything You Need to Know About CA 19-9 and Cancer Diagnosis

5.

Exploring The Causes and Consequences of Low Transferrin Saturation

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot